PS216. Angiogenesis Inhibitor Sunitinib Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysm  by Iida, Yasunori et al.
Objectives: Autogenous vein and PTFE are two
common conduits used to bypass arterial injuries. PTFE
is prone to infection and subsequent graft failure in
contaminated wounds. Biosynthetic materials used as
conduit are potentially more resistant to infection than
PTFE. The objective of this study is to compare Perma-
col, a biosynthetic material, to vein as a vascular conduit
for arterial repair in the presence of bacterial
contamination.
Methods: Thirty six New Zealand white rabbits were
randomized to one of four groups: Permacol or autoge-
nous vein graft, with or without bacterial contamination
(n  9). All groups underwent interposition grafting of
the common carotid artery. Grafts were contaminated
with Staphylococcus aureus upon completion of surgery.
Grafts were then excised at day 42 and segments were
collected for histological evaluation and bacterial load
measurement.
Results: Three animals in the contaminated vein
group died within 72 hours of surgery. There were no
deaths in the other groups. At 42 days, Permacol dem-
onstrated greater patency than vein in the contaminated
groups (P  .05) and equivalent patency in the non-
contaminated group. No difference was found between
the 2 contaminated groups in the bacterial content of
graft material at 42 days.
Conclusions: When used as a conduit in a contami-
nated field, Permacol was equivalent to autogenous vein
graft with respect to patency and bacterial contamination.
When contaminated, Permacol was associated with better
survival rates as compared to autogenous vein. Permacol
may function as an alternative to autogenous vein as a
vascular conduit.
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Objectives: Muscle regeneration is an ongoing pro-
cess which is increased after injury. Whether aging has
any effect on this process is an ongoing question. The
present study examined myofiber size and adipocyte
accumulation within regenerated muscle in a murine
model of aging.
Methods: Three age groups of C57Bl/6J mice were
studied: young (4-6 months old), middle (12-14
months) and old (25 months). Cardiotoxin was in-
jected to cause muscle injury. After fourteen days, light
microscopic histomorphometry was used to quantitate
tibialis anterior myofiber size and intramuscular adi-
pocyte content.
Results: At baseline, young and middle aged male
mice had similar fiber size while older mice had smaller
myofibers (2628  52.1, 2797  62.7, 2090 
124.9m2 respectively). Female mice showed a similar
pattern (2115 68.4, 2077 60.7, 1499 206.5 m2
respectively). After injury, male mice demonstrated sim-
ilar myofiber size when compared to baseline (1632 
101.6, 1523  43.6, 1402  75.1 m2, from young to
old). Females similar comparative results (1624  81.5,
1423  36.9, 1326  68.4 m2 respectively). Fat was
zero at baseline for both male and female mice regardless
of age. Following injury, male mice had similar adipocyte
accumulation when compared to each other while fe-
males accumulated two to four times the amount of fat
that males did at the same time point.
Conclusions: Muscle regeneration is not significantly
affected by aging. Female mice gain more adipose tissue
after injury than males; however, this is not related to
increasing age.
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Objectives: Mural angiogenesis is a prominent patho-
logic feature in abdominal aortic aneurysm (AAA) disease.
We evaluated the effect of sunitinib, an FDA-approved
angiogenesis inhibitor, on the formation and progression
of experimental AAA.
Methods: AAAs were created via by intraaortic PPE
infusion in 10-wk-old male C57BL/6 mice. Oral
sunitinib (or vehicle alone) was administered either from
1) 3 days prior to PPE infusion, or 2) 5 days thereafter -
until sacrifice. Aortic diameter was serially monitored via
ultrasound, and aortae harvested for histopathology at
14 days.
Results: AAA (defined as 50% diameter increase)
developed in all vehicle-treated mice (n4-7 mice).
Sunitinib treatment initiated prior to PPE infusion at 4,
20 or 100 mg/kg/day prevented AAA formation
(n3-7 mice). Additionally, sunitinib initiated after PPE
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infusion at 4 or 100 mg/kg stabilized and reduced AAA
diameter, respectively, compared to immediate pre-
treatment diameter. Sunitinib preserved aortic medial
elastin and smooth muscle cellularity, while reducing
medial/adventitial angiogenesis and monocytes/macro-
phages density.
Conclusions: Sunitinib therapy suppresses AAA for-
mation, as well as stabilizing or regressing aortic diame
ter in existing aneurysms in a dose-dependent fashion.
Similar strategies may prove effective in suppressing or
stabilizing early AAA disease.
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Fig. A andB, Sunitinib was daily given to 10-12 week old male C57BL/6mice at 100mg/kg (A, n 34) or 4mg/kg
(B, n  7) from 3 days prior to PPE infusion for 17 days. Data are mean and SD of aortic diameters measured by
ultrasound. ANOVA, **P .01 compared to vehicle-treated group. C and D, Sunitinib was daily given to mice at 100
mg/kg (C, n 3-7) or 4mg/kg (D, n 7) 5 days after PPE infusion for 9 days. Data are mean and SD of delta changes
in aortic diameters after sunitinib or vehicle treatment. ANOVA, *P  .05 and **P .01 compared to vehicle-treated
group.
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